Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 163

1.

Correction for Sakwinska et al., "Nasopharyngeal Microbiota in Healthy Children and Pneumonia Patients".

Sakwinska O, Bastic Schmid V, Berger B, Bruttin A, Keitel K, Lepage M, Moine D, Ngom Bru C, Brüssow H, Gervaix A.

J Clin Microbiol. 2019 May 24;57(6). pii: e00417-19. doi: 10.1128/JCM.00417-19. Print 2019 Jun. No abstract available.

2.
3.

Microbial-derived products as potential new antimicrobials.

Seal BS, Drider D, Oakley BB, Brüssow H, Bikard D, Rich JO, Miller S, Devillard E, Kwan J, Bertin G, Reeves S, Swift SM, Raicek M, Gay CG.

Vet Res. 2018 Jul 31;49(1):66. doi: 10.1186/s13567-018-0563-5. Review.

4.

Metagenome analysis of Russian and Georgian Pyophage cocktails and a placebo-controlled safety trial of single phage versus phage cocktail in healthy Staphylococcus aureus carriers.

McCallin S, Sarker SA, Sultana S, Oechslin F, Brüssow H.

Environ Microbiol. 2018 Sep;20(9):3278-3293. doi: 10.1111/1462-2920.14310. Epub 2018 Sep 2.

PMID:
30051571
5.

ACI-1 beta-lactamase is widespread across human gut microbiomes in Negativicutes due to transposons harboured by tailed prophages.

Rands CM, Starikova EV, Brüssow H, Kriventseva EV, Govorun VM, Zdobnov EM.

Environ Microbiol. 2018 Jun;20(6):2288-2300. doi: 10.1111/1462-2920.14276. Epub 2018 Aug 7.

PMID:
30014616
6.

Bangladeshi children with acute diarrhoea show faecal microbiomes with increased Streptococcus abundance, irrespective of diarrhoea aetiology.

Kieser S, Sarker SA, Sakwinska O, Foata F, Sultana S, Khan Z, Islam S, Porta N, Combremont S, Betrisey B, Fournier C, Charpagne A, Descombes P, Mercenier A, Berger B, Brüssow H.

Environ Microbiol. 2018 Jun;20(6):2256-2269. doi: 10.1111/1462-2920.14274. Epub 2018 Aug 7.

PMID:
29786169
7.

Antibiotic Treatment Leads to Fecal Escherichia coli and Coliphage Expansion in Severely Malnourished Diarrhea Patients.

Kieser S, Sarker SA, Berger B, Sultana S, Chisti MJ, Islam SB, Foata F, Porta N, Betrisey B, Fournier C, Descombes P, Mercenier A, Sakwinska O, Brüssow H.

Cell Mol Gastroenterol Hepatol. 2017 Dec 13;5(3):458-460.e6. doi: 10.1016/j.jcmgh.2017.11.014. eCollection 2018 Mar. No abstract available.

8.

Environmental microbiology: Too much food for thought? - An argument for reductionism.

Brüssow H.

Environ Microbiol. 2018 Jun;20(6):1929-1935. doi: 10.1111/1462-2920.14125. Epub 2018 May 11. No abstract available.

PMID:
29626370
9.

Does the maternal vaginal microbiota play a role in seeding the microbiota of neonatal gut and nose?

Sakwinska O, Foata F, Berger B, Brüssow H, Combremont S, Mercenier A, Dogra S, Soh SE, Yen JCK, Heong GYS, Lee YS, Yap F, Meaney MJ, Chong YS, Godfrey KM, Holbrook JD.

Benef Microbes. 2017 Oct 13;8(5):763-778. doi: 10.3920/BM2017.0064. Epub 2017 Oct 12.

PMID:
29022384
10.

The contribution of microbial biotechnology to economic growth and employment creation.

Timmis K, de Lorenzo V, Verstraete W, Ramos JL, Danchin A, Brüssow H, Singh BK, Timmis JK.

Microb Biotechnol. 2017 Sep;10(5):1137-1144. doi: 10.1111/1751-7915.12845. Epub 2017 Sep 4.

11.

The contribution of microbial biotechnology to sustainable development goals.

Timmis K, de Vos WM, Ramos JL, Vlaeminck SE, Prieto A, Danchin A, Verstraete W, de Lorenzo V, Lee SY, Brüssow H, Timmis JK, Singh BK.

Microb Biotechnol. 2017 Sep;10(5):984-987. doi: 10.1111/1751-7915.12818. Epub 2017 Aug 25.

12.

Persistent diarrhea: a persistent infection with enteropathogens or a gut commensal dysbiosis?

Sarker SA, Ahmed T, Brüssow H.

Environ Microbiol. 2017 Oct;19(10):3789-3801. doi: 10.1111/1462-2920.13873. Epub 2017 Sep 14.

PMID:
28752952
13.

Infection therapy: the problem of drug resistance - and possible solutions.

Brüssow H.

Microb Biotechnol. 2017 Sep;10(5):1041-1046. doi: 10.1111/1751-7915.12777. Epub 2017 Jul 24.

14.

Hunger and microbiology: is a low gastric acid-induced bacterial overgrowth in the small intestine a contributor to malnutrition in developing countries?

Sarker SA, Ahmed T, Brüssow H.

Microb Biotechnol. 2017 Sep;10(5):1025-1030. doi: 10.1111/1751-7915.12780. Epub 2017 Jul 17.

15.

Adjuncts and alternatives in the time of antibiotic resistance and in-feed antibiotic bans.

Brüssow H.

Microb Biotechnol. 2017 Jul;10(4):674-677. doi: 10.1111/1751-7915.12730. No abstract available.

16.

Phage therapy for the treatment of human intestinal bacterial infections: soon to be a reality?

Brüssow H.

Expert Rev Gastroenterol Hepatol. 2017 Sep;11(9):785-788. doi: 10.1080/17474124.2017.1342534. Epub 2017 Jun 19. Review. No abstract available.

PMID:
28612636
17.

What happened to Koch's postulates in diarrhoea?

Sultana S, Sarker SA, Brüssow H.

Environ Microbiol. 2017 Aug;19(8):2926-2934. doi: 10.1111/1462-2920.13787. Epub 2017 May 29.

PMID:
28474475
18.

Is chronic rhinosinusitis an infectious disease? Insights from a microbiota meta-analysis.

Brüssow H.

Environ Microbiol. 2017 Apr;19(4):1359-1362. doi: 10.1111/1462-2920.13715. Epub 2017 Mar 29. No abstract available.

PMID:
28256064
19.

Oral application of Escherichia coli bacteriophage: safety tests in healthy and diarrheal children from Bangladesh.

Sarker SA, Berger B, Deng Y, Kieser S, Foata F, Moine D, Descombes P, Sultana S, Huq S, Bardhan PK, Vuillet V, Praplan F, Brüssow H.

Environ Microbiol. 2017 Jan;19(1):237-250. doi: 10.1111/1462-2920.13574. Epub 2016 Nov 13.

PMID:
27750388
20.

Biome engineering-2020.

Brüssow H.

Microb Biotechnol. 2016 Sep;9(5):553-63. doi: 10.1111/1751-7915.12391. Epub 2016 Jul 29. Review.

21.

How stable is the human gut microbiota? And why this question matters.

Brüssow H.

Environ Microbiol. 2016 Sep;18(9):2779-83. doi: 10.1111/1462-2920.13473. Epub 2016 Aug 25. No abstract available.

PMID:
27459371
22.

From bench to bed and back again: phage therapy of childhood Escherichia coli diarrhea.

Sarker SA, Brüssow H.

Ann N Y Acad Sci. 2016 May;1372(1):42-52. doi: 10.1111/nyas.13087. Epub 2016 May 19. Review.

PMID:
27197768
23.

Targeting the gut to protect the bladder: Oral Phage therapy approaches against urinary Escherichia coli infections?

Brüssow H.

Environ Microbiol. 2016 Jul;18(7):2084-8. doi: 10.1111/1462-2920.13310. Epub 2016 Apr 30. No abstract available.

PMID:
27059692
24.

Oral Phage Therapy of Acute Bacterial Diarrhea With Two Coliphage Preparations: A Randomized Trial in Children From Bangladesh.

Sarker SA, Sultana S, Reuteler G, Moine D, Descombes P, Charton F, Bourdin G, McCallin S, Ngom-Bru C, Neville T, Akter M, Huq S, Qadri F, Talukdar K, Kassam M, Delley M, Loiseau C, Deng Y, El Aidy S, Berger B, Brüssow H.

EBioMedicine. 2016 Jan 5;4:124-37. doi: 10.1016/j.ebiom.2015.12.023. eCollection 2016 Feb.

25.

Bacteriophages or bacteriovores - that is the question: variations on the theme of eating Stenotrophomonas maltophilia.

Brüssow H.

Environ Microbiol Rep. 2016 Jun;8(3):328-31. doi: 10.1111/1758-2229.12399. Epub 2016 Apr 29. No abstract available.

PMID:
26971712
26.

Bacteriophage Therapy: Advances in Formulation Strategies and Human Clinical Trials.

Vandenheuvel D, Lavigne R, Brüssow H.

Annu Rev Virol. 2015 Nov;2(1):599-618. doi: 10.1146/annurev-virology-100114-054915. Review.

PMID:
26958930
27.

Gut microbiota analysis reveals a marked shift to bifidobacteria by a starter infant formula containing a synbiotic of bovine milk-derived oligosaccharides and Bifidobacterium animalis subsp. lactis CNCM I-3446.

Simeoni U, Berger B, Junick J, Blaut M, Pecquet S, Rezzonico E, Grathwohl D, Sprenger N, Brüssow H; Study Team, Szajewska H, Bartoli JM, Brevaut-Malaty V, Borszewska-Kornacka M, Feleszko W, François P, Gire C, Leclaire M, Maurin JM, Schmidt S, Skórka A, Squizzaro C, Verdot JJ.

Environ Microbiol. 2016 Jul;18(7):2185-95. doi: 10.1111/1462-2920.13144. Epub 2016 Jan 18.

28.

Rate of establishing the gut microbiota in infancy has consequences for future health.

Dogra S, Sakwinska O, Soh SE, Ngom-Bru C, Brück WM, Berger B, Brüssow H, Karnani N, Lee YS, Yap F, Chong YS, Godfrey KM, Holbrook JD.

Gut Microbes. 2015;6(5):321-5. doi: 10.1080/19490976.2015.1078051. Epub 2015 Aug 20.

29.

Turning the inside out: the microbiology of atopic dermatitis.

Brüssow H.

Environ Microbiol. 2016 Jul;18(7):2089-102. doi: 10.1111/1462-2920.13050. Epub 2015 Dec 4. Review.

PMID:
26373255
30.

Dynamics of infant gut microbiota are influenced by delivery mode and gestational duration and are associated with subsequent adiposity.

Dogra S, Sakwinska O, Soh SE, Ngom-Bru C, Brück WM, Berger B, Brüssow H, Lee YS, Yap F, Chong YS, Godfrey KM, Holbrook JD; GUSTO Study Group.

MBio. 2015 Feb 3;6(1). pii: e02419-14. doi: 10.1128/mBio.02419-14.

31.

Growth promotion and gut microbiota: insights from antibiotic use.

Brüssow H.

Environ Microbiol. 2015 Jul;17(7):2216-27. doi: 10.1111/1462-2920.12786. Epub 2015 Mar 10. Review.

PMID:
25627910
32.

Human microbiota: 'the philosophers have only interpreted the world in various ways. The point, however, is to change it'.

Brüssow H.

Microb Biotechnol. 2015 Jan;8(1):11-2. doi: 10.1111/1751-7915.12259. No abstract available.

33.

Microbiota and the human nature: know thyself.

Brüssow H.

Environ Microbiol. 2015 Jan;17(1):10-5. doi: 10.1111/1462-2920.12693. Epub 2014 Dec 17.

PMID:
25521462
34.

You are what you eat.

Brüssow H, Parkinson SJ.

Nat Biotechnol. 2014 Mar;32(3):243-5. doi: 10.1038/nbt.2845. No abstract available.

PMID:
24727777
35.

Nasopharyngeal microbiota in healthy children and pneumonia patients.

Sakwinska O, Bastic Schmid V, Berger B, Bruttin A, Keitel K, Lepage M, Moine D, Ngom Bru C, Brüssow H, Gervaix A.

J Clin Microbiol. 2014 May;52(5):1590-4. doi: 10.1128/JCM.03280-13. Epub 2014 Mar 5. Erratum in: J Clin Microbiol. 2019 May 24;57(6):.

36.

Coverage of diarrhoea-associated Escherichia coli isolates from different origins with two types of phage cocktails.

Bourdin G, Navarro A, Sarker SA, Pittet AC, Qadri F, Sultana S, Cravioto A, Talukder KA, Reuteler G, Brüssow H.

Microb Biotechnol. 2014 Mar;7(2):165-76. doi: 10.1111/1751-7915.12113.

37.

Amplification and purification of T4-like escherichia coli phages for phage therapy: from laboratory to pilot scale.

Bourdin G, Schmitt B, Marvin Guy L, Germond JE, Zuber S, Michot L, Reuteler G, Brüssow H.

Appl Environ Microbiol. 2014 Feb;80(4):1469-76. doi: 10.1128/AEM.03357-13. Epub 2013 Dec 20.

38.

Phage therapy: quo vadis?

Brüssow H.

Clin Infect Dis. 2014 Feb;58(4):535-6. doi: 10.1093/cid/cit776. Epub 2013 Nov 23. No abstract available.

PMID:
24270168
39.

Safety analysis of a Russian phage cocktail: from metagenomic analysis to oral application in healthy human subjects.

McCallin S, Alam Sarker S, Barretto C, Sultana S, Berger B, Huq S, Krause L, Bibiloni R, Schmitt B, Reuteler G, Brüssow H.

Virology. 2013 Sep 1;443(2):187-96. doi: 10.1016/j.virol.2013.05.022. Epub 2013 Jun 10.

40.

Bacteriophage-host interaction: from splendid isolation into a messy reality.

Brüssow H.

Curr Opin Microbiol. 2013 Aug;16(4):500-6. doi: 10.1016/j.mib.2013.04.007. Epub 2013 May 28. Review.

PMID:
23725668
41.

What is health?

Brüssow H.

Microb Biotechnol. 2013 Jul;6(4):341-8. doi: 10.1111/1751-7915.12063. Epub 2013 May 6. Review.

42.

Nutrition, population growth and disease: a short history of lactose.

Brüssow H.

Environ Microbiol. 2013 Aug;15(8):2154-61. doi: 10.1111/1462-2920.12117. Epub 2013 Apr 9. Review.

PMID:
23574334
43.

Microbiota and healthy ageing: observational and nutritional intervention studies.

Brüssow H.

Microb Biotechnol. 2013 Jul;6(4):326-34. doi: 10.1111/1751-7915.12048. Epub 2013 Mar 26. Review.

44.

Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh.

Sarker SA, McCallin S, Barretto C, Berger B, Pittet AC, Sultana S, Krause L, Huq S, Bibiloni R, Bruttin A, Reuteler G, Brüssow H.

Virology. 2012 Dec 20;434(2):222-32. doi: 10.1016/j.virol.2012.09.002. Epub 2012 Oct 24.

45.

What is needed for phage therapy to become a reality in Western medicine?

Brüssow H.

Virology. 2012 Dec 20;434(2):138-42. doi: 10.1016/j.virol.2012.09.015. Epub 2012 Oct 9.

46.

Shiga toxin-producing Escherichia coli O104:H4: a new challenge for microbiology.

Muniesa M, Hammerl JA, Hertwig S, Appel B, Brüssow H.

Appl Environ Microbiol. 2012 Jun;78(12):4065-73. doi: 10.1128/AEM.00217-12. Epub 2012 Apr 13. Review.

47.

Pseudomonas biofilms, cystic fibrosis, and phage: a silver lining?

Brüssow H.

MBio. 2012 Apr 3;3(2). pii: e00061-12. doi: 10.1128/mBio.00061-12. Print 2012.

48.

Campylobacter jejuni group III phage CP81 contains many T4-like genes without belonging to the T4-type phage group: implications for the evolution of T4 phages.

Hammerl JA, Jäckel C, Reetz J, Beck S, Alter T, Lurz R, Barretto C, Brüssow H, Hertwig S.

J Virol. 2011 Sep;85(17):8597-605. doi: 10.1128/JVI.00395-11. Epub 2011 Jun 22.

49.

In vivo replication of T4 and T7 bacteriophages in germ-free mice colonized with Escherichia coli.

Weiss M, Denou E, Bruttin A, Serra-Moreno R, Dillmann ML, Brüssow H.

Virology. 2009 Oct 10;393(1):16-23. doi: 10.1016/j.virol.2009.07.020. Epub 2009 Aug 21.

50.

The not so universal tree of life or the place of viruses in the living world.

Brüssow H.

Philos Trans R Soc Lond B Biol Sci. 2009 Aug 12;364(1527):2263-74. doi: 10.1098/rstb.2009.0036.

Supplemental Content

Loading ...
Support Center